Nitric Oxide-Releasing Topical Therapeutic Agent for Atopic Dermatitis

    Kimberly McHale, Joel Gil, S C Davis, Stan Hollenbach, Nathan Stasko
    Image
    Studysummary In this study, the novel isoprenylcysteine analog SIG-1451 was shown to inhibit pro-inflammatory cytokine release in various cell-based assays relevant to allergic dermatitis, acting on targets such as IL-4 and IL-6 with potential anti-inflammatory benefits.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community →